Tien Liang BioTech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 10, 2021
Share
Tien Liang BioTech Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 158.83 million compared to TWD 96.29 million a year ago. Net income was TWD 20.67 million compared to net loss of TWD 18.27 million a year ago. Basic earnings per share from continuing operations was TWD 0.45 compared to basic loss per share from continuing operations of TWD 0.4 a year ago.
For the nine months, sales was TWD 407.88 million compared to TWD 320.95 million a year ago. Net income was TWD 20.62 million compared to net loss of TWD 38.35 million a year ago. Basic earnings per share from continuing operations was TWD 0.45 compared to basic loss per share from continuing operations of TWD 0.84 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.